Monthly Archives: June 2012

THE CURRENT INCREASE OF CARDIOVASCULAR DISEASE

Posted on June 6, 2012 by everist

During the last several years, scientific research has expanded our understanding of heart disease, its causes and prevention. Recently, a host of previously unsuspected factors and conditions have been identified and linked to heart disease, including inflammatory diseases (such as … Continue reading →

Posted in blog | Leave a comment

Everist Genomics Announces Publication of Validation Study Confirming OncoDefender-CRC Independently Predicts Recurrence Risk for Early Stage Colorectal Cancer Patients

Posted on June 4, 2012 by admin

- Findings Published in CANCER Support Clinical Use of OncoDefender-CRC for Personalizing Treatment Planning for CRC Patients – Ann Arbor, Michigan June 4, 2012 – Everist Genomics, a rapidly growing personalized medicine company, today announced the publication of positive results … Continue reading →

Posted in press releases | Leave a comment

SMARTPHONES AND THE FUTURE OF PERSONALIZED MEDICINE

Posted on June 1, 2012 by everist

The Growth of Smartphone Utilization iPhone sales now outpace births. In the December quarter, Apple sold 37 million iPhones at an average rate of 4.6 per second. The current global birth rate is 4.2 per second. Based on this kind … Continue reading →

Posted in blog | Leave a comment